D- (RYTVELA)
D- (RYTVELA) is a specific inhibitor of human thymocyte proliferation with an IC50 of 1 nM. d- (RYTVELA) inhibits IL-1–induced signaling pathways[1].
Product Specifications
CAS Number
[868844-53-5]
UNSPSC
12352209
Target
Interleukin Related
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/d-rytvela.html
Solubility
10 mM in DMSO
Smiles
OC(C=C1)=CC=C1C[C@@H](NC([C@H](N)CCCNC(N)=N)=O)C(N[C@H]([C@@H](O)C)C(N[C@H](C(C)C)C(N[C@H](CCC(O)=O)C(N[C@H](CC(C)C)C(N[C@H](C)C(O)=O)=O)=O)=O)=O)=O
Molecular Formula
C38H62N10O12
Molecular Weight
850.96
References & Citations
[1]Tiffany Habelrih, et al. Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomes. Am J Obstet Gynecol. 2023, 228, 4.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15091194 1 Vial
Lentiviral human CYP2A13 shRNA (UAS) - Lentiviral human CYP2A13 shRNA (UAS) (100)
Ask
View Details 